At-home gut microbiome tests: patients should exercise caution
The results and interpretations of at-home gut microbiome tests vary so widely from one company to another that their reliability and clinical utility are widely questioned.
Lay public section
Find here your dedicated section
Sources
This article is based on scientific information
About this article
Mental health disorders, cancer, obesity: human gut microbiota has been linked to numerous diseases since the early 2000s. Thanks to extensive media coverage, studies are encouraging consumers to “test” their gut health. A potentially lucrative market for sellers of self-test kits: consumers collect a stool sample at home, send it to the lab and receive the results directly.
+7.7% per year
The global self-testing market (all tests combined) was valued at $21.9 billion in 2025.
It is expected to grow from $23.7 billion in 2026 to $46.1 billion in 2035, representing an annual growth rate of 7.7%. 1
7 self-tests under scrutiny
A team 2 compared the performance of seven gut microbiome testing services by submitting three replicates of a standardized human stool sample to each, the kind laboratories typically use for calibration.
First observation: microbiome testing methods vary greatly between companies (collection procedures, sequencing, analysis), with no common standard.
27% Around 1 in 4 people surveyed (27%) had already heard about microbiome testing. ³
60% 6 out of 10 respondents (60%) would be willing to have their gut microbiota tested as part of a general health checkup (60%), while 23% would do so out of curiosity. ³
Second limitation: results vary significantly from one company to another.
- Of the seven companies tested, three detected the presence of Clostridioides difficile in the standardized sample, while the other four reported it as absent.
- Only one genus (Streptococcus) showed consistent results across all methods, while Roseburia showed the greatest discrepancy.
- In some cases, differences in results for a same sample exceeded the biological variations seen between individuals!
- Finally, the same company sometimes reported inconsistent results after analyzing the same standard sample three times.
20% Only 2 out of 10 respondents (20%) would have their gut microbiota tested to help balance their microbiota, or to prevent or slow the progression of disease. ³
31% 3 out of 10 participants (31%) would be willing to have their microbiota tested to help advance microbiota science. ³
A final challenge: interpretation of results.
Because there is no universal definition of a healthy microbiota, each company uses its own reference values for several key bacteria. As a result, the findings vary from one company to another.
Worse still: within a same company, results can vary across replicates, sometimes leading to conflicting recommendations (with the microbiota deemed “healthy” or “unhealthy” depending on the replicate). These differences—both between and within companies—lead to inconsistent health interpretations and advice.
Diversity or function: what defines a healthy microbiota
The authors’ recommendations
Recognizing the demand from patients seeking answers to their health issues, the authors recommend two main areas for improvement:
- Improve clinical validity by consistently citing the literature for each health interpretation to justify statements and recommendations, and distinguishing between simple correlations and true causal relationships.
- Strengthen analytical performance and transparency through quality control standards (reference materials, known microbial communities, minimum detection limits).
They also emphasize the need to develop common guidelines for the industry, drawing on best practices from other diagnostic fields, in order to harmonize practices and build confidence among users and regulatory authorities.
